AN OPEN LABEL PHASE I STUDY TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF HBI INACTIVATED HEPATITIS-A VACCINE WHEN ADMINISTERED AS A SINGLE DOSE IN TWO GROUPS OF HEALTHY SUBJECTS OF 19 TO 49 YEARS AND 12 TO 18 YEARS OF AGE - Hepatitis A Vaccine

Trial Profile

AN OPEN LABEL PHASE I STUDY TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF HBI INACTIVATED HEPATITIS-A VACCINE WHEN ADMINISTERED AS A SINGLE DOSE IN TWO GROUPS OF HEALTHY SUBJECTS OF 19 TO 49 YEARS AND 12 TO 18 YEARS OF AGE - Hepatitis A Vaccine

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Sep 2018

At a glance

  • Drugs Hepatitis A vaccine (Primary)
  • Indications Hepatitis A
  • Focus Adverse reactions
  • Most Recent Events

    • 11 Sep 2018 Status changed from recruiting to completed.
    • 08 Jan 2018 Status changed from not yet recruiting to recruiting.
    • 05 Jan 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top